NCT04756375View on ClinicalTrials.gov

Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

September 2, 2021

Study Completion Date

September 2, 2021

Conditions
Vaso-occlusive CrisisSickle Cell Disease
Interventions
DEVICE

Virtual Reality

Use of virtual reality in the management of sickle cell patients with VOS

OTHER

Usual Care

Usual management of sickle cell patients with VOS

Trial Locations (1)

75020

HOPITAL TENON Service des urgences, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04756375 - Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room | Biotech Hunter | Biotech Hunter